375 results on '"Micoli, Francesca"'
Search Results
2. Outer Membrane Vesicle Vaccine Platforms
3. Quality by Design Framework Applied to GMMA Purification
4. Vaccine value profile for Klebsiella pneumoniae
5. A next-generation GMMA-based vaccine candidate to fight shigellosis
6. Strengths and weaknesses of pneumococcal conjugate vaccines
7. From an in vivo to an in vitro relative potency (IVRP) assay to fully characterize a multicomponent O-antigen based vaccine against Shigella
8. Elucidating the role of N-acetylglucosamine in Group A Carbohydrate for the development of an effective glycoconjugate vaccine against Group A Streptococcus
9. Study of Agonists of TLRs as Vaccine Adjuvants
10. Rapid generation of Shigella flexneri GMMA displaying natural or new and cross-reactive O-Antigens
11. Development of a visual Adhesion/Invasion Inhibition Assay to assess the functionality of Shigella-specific antibodies
12. Development and Application of a High-Throughput Method for the Purification and Analysis of Surface Carbohydrates from Klebsiella pneumoniae
13. Putative correlates of protection against shigellosis assessing immunomarkers across responses to S. sonnei investigational vaccine
14. O-Antigen decorations in Salmonella enterica play a key role in eliciting functional immune responses against heterologous serovars in animal models
15. Age-dependent acquisition of IgG antibodies to Shigella serotypes—a retrospective analysis of seroprevalence in Kenyan children with implications for infant vaccination
16. Short Vi-polysaccharide abrogates T-independent immune response and hyporesponsiveness elicited by long Vi-CRM 197 conjugate vaccine
17. Efficacy, safety, and immunogenicity of the Shigella sonnei 1790GAHB GMMA candidate vaccine: Results from a phase 2b randomized, placebo-controlled challenge study in adults
18. Carbohydrate based meningococcal vaccines: past and present overview
19. Methods for Assessment of OMV/GMMA Quality and Stability
20. The role of vaccines in combatting antimicrobial resistance
21. Modeling 1-Cyano-4-Dimethylaminopyridine Tetrafluoroborate (CDAP) Chemistry to Design Glycoconjugate Vaccines with Desired Structural and Immunological Characteristics.
22. Vaccines and Monoclonal Antibodies as Alternative Strategies to Antibiotics to Fight Antimicrobial Resistance.
23. Structure, dynamics and immunogenicity of a catalytically inactive CXC chemokine-degrading protease SpyCEP from Streptococcus pyogenes
24. Molecular Signature of Monocytes Shaped by the Shigella sonnei 1790-Generalized Modules for Membrane Antigens Vaccine
25. Testing a Recombinant Form of Tetanus Toxoid as a Carrier Protein for Glycoconjugate Vaccines
26. Comparison of Shigella GMMA and glycoconjugate four-component formulations in animals
27. Dissecting the contribution of O-Antigen and proteins to the immunogenicity of Shigella sonnei generalized modules for membrane antigens (GMMA)
28. Characterization of the Salmonella Typhimurium core oligosaccharide and its reducing end 3-deoxy-d-manno-oct-2-ulosonic acid used for conjugate vaccine production
29. Testing S. sonnei GMMA with and without Aluminium Salt-Based Adjuvants in Animal Models.
30. Towards establishing correlates of protection against shigellosis: assessing immunological endpoints across immune responses to the Shigella sonnei Generalized Modules for Membrane Antigens (GMMA) candidate vaccine (1790GAHB).
31. Comparative immunogenicity and efficacy of equivalent outer membrane vesicle and glycoconjugate vaccines against nontyphoidal Salmonella
32. O-Antigen Extraction, Purification, and Chemical Conjugation to a Carrier Protein
33. Contributors
34. Glycoconjugate vaccines, production and characterization
35. Exploring the variables influencing the immune response of traditional and innovative glycoconjugate vaccines
36. Functional assays to evaluate antibody-mediated responses against Shigella: a review
37. Efficient Autotransporter-Mediated Extracellular Secretion of a Heterologous Recombinant Protein by Escherichia coli
38. Vi polysaccharide and conjugated vaccines afford similar early, IgM or IgG-independent control of infection but boosting with conjugated Vi vaccines sustains the efficacy of immune responses
39. Toward a Shigella Vaccine: Opportunities and Challenges to Fight an Antimicrobial-Resistant Pathogen
40. Exploring the Role of GMMA Components in the Immunogenicity of a 4-Valent Vaccine against Shigella
41. Simplified low-cost production of O-antigen from Salmonella Typhimurium Generalized Modules for Membrane Antigens (GMMA)
42. Generalized Modules for Membrane Antigens (GMMA), an outer membrane vesicle‐based vaccine platform, for efficient viral antigen delivery
43. Impact and Control of Sugar Size in Glycoconjugate Vaccines
44. Antigen presentation by Follicular Dendritic cells to cognate B cells is pivotal for Generalised Modules for Membrane Antigens (GMMA) immunogenicity
45. Complement-mediated serum bactericidal activity of antibodies elicited by the Shigella sonnei GMMA vaccine in adults from a shigellosis-endemic country: Exploratory analysis of a Phase 2a randomized study
46. Genetic and Structural Variation in the O-Antigen of Salmonella enterica Serovar Typhimurium Isolates Causing Bloodstream Infections in the Democratic Republic of the Congo
47. Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X
48. Enhanced Systemic Humoral Immune Response Induced in Mice by Generalized Modules for Membrane Antigens (GMMA) Is Associated with Affinity Maturation and Isotype Switching.
49. Setup and Characterization of a High-Throughput Luminescence-Based Serum Bactericidal Assay (L-SBA) to Determine Functionality of Human Sera against Shigella flexneri
50. Investigating the Role of Antigen Orientation on the Immune Response Elicited by Neisseria meningitidis Factor H Binding Protein on GMMA
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.